Advertisement

Letters in Peptide Science

, Volume 5, Issue 1, pp 37–41 | Cite as

Biochemical pharmacology of total retro-inverso analogues of bradykinin and angiotensin II: Molecular recognition by G-protein-coupled receptors and angiotensin converting enzyme

  • John Howl
  • Mark Wheatley
Article
  • 23 Downloads

Abstract

Total retro-inverso (TRI) analogues of bradykinin (BK), the B2a-selective kinin antagonist d-Arg0[Hyp3,d-Phe7,Leu8]BK, angiotensin II (AT II) and the AT II antagonist Saralasin ([Sar1,Val5,Ala8]AT II) were prepared by conventional solid-phase synthesis. Molecular recognition of TRI peptidomimetics by G-protein-coupled receptors was studied by competitive radioligand displacement experiments. TRI analogues of d-Arg0[Hyp3,d-Phe7,Leu8]BK specifically bound to the kidney medulla B2a bradykinin receptor with affinities (Kd) ranging from 64 μM to 4 μM. Conversely, TRI analogues of BK, AT II and Saralasin did not bind to either the B2a bradykinin receptor or the rat AT1a AT II receptor, respectively. These studies indicate that the TRI strategy is more compatible with the synthesis of antagonists than ‘agonists’. Three TRI peptidomimetics of d-Arg0[Hyp3,d-Phe7,Leu8]BK were weak inhibitors of angiotensin converting enzyme. All other TRI peptidomimetics had no effect upon ACE activity. These data endorse the utility of the TRI strategy for the synthesis of protease-resistant antagonists of peptide hormones and neuropeptides.

agonist antagonist hormone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chorev, L. and Goodman, M., Acc. Chem. Res., 26 (1993) 266.Google Scholar
  2. 2.
    Stewart, J., Biopolymers, 37 (1995) 143.PubMedGoogle Scholar
  3. 3.
    Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A. and Smith, R.D., Pharmacol. Rev., 45 (1993) 205.PubMedGoogle Scholar
  4. 4.
    Bumpus, F.M., Fed. Proc., 8 (1977) 2128.Google Scholar
  5. 5.
    Graier, W., Schmidt, K. and Kukovetz, W.R., Eur. J. Pharmacol., 225 (1992) 43.PubMedGoogle Scholar
  6. 6.
    Yang, H.Y.T., Erdös, E.G. and Levin, Y., Biochem. Biophys. Acta, 214 (1970) 374.PubMedGoogle Scholar
  7. 7.
    Triggle, D.J., Clin. Ther., 17 (1995) 1005.PubMedGoogle Scholar
  8. 8.
    Margolius, H.S., Annu. Rev. Pharmacol. Toxicol., 29 (1989) 343.PubMedGoogle Scholar
  9. 9.
    Regoli, D., Rhaleb, N.-E., Dion, S. and Drapeau, G., Trends Pharmacol. Sci., 11 (1990) 156.PubMedGoogle Scholar
  10. 10.
    Howl, J., Langel, Ñ., Hawtin, S.R., Valkna, A., Yaarwood, N.J., Saar, K. and Wheatley, M., FASEB J., 11 (1997) 582.PubMedGoogle Scholar
  11. 11.
    Howl, J. and Wheatley, M., Methods Neurosci., 13 (1993) 281.Google Scholar
  12. 12.
    Howl, J., Yarwood, N.J., Davies, A.R.L. and Wheatley, M., Kidney Int., 50 (1996) 586.PubMedGoogle Scholar
  13. 13.
    Regoli, D., Gobeil, F., Nguyen, Q.T., Jukic, D., Seoane, P.R., Salvino, J.M. and Sawutz, D.G., Life Sci., 55 (1994) 735.PubMedGoogle Scholar
  14. 14.
    Howl, J. and Wheatley, M., Biochem. J., 317 (1996) 577.PubMedGoogle Scholar
  15. 15.
    Cheng, Y. and Prusoff, W.H., Biochem. Pharmacol., 22 (1973) 3099.CrossRefPubMedGoogle Scholar
  16. 16.
    Bünning, P. and Riordan, J.F., Biochemistry, 22 (1983) 110.PubMedGoogle Scholar
  17. 17.
    Pals, D.T., Masucci, F.D., Denning Jr., J.S., Sipos, F. and Fessler, D.C., Circ. Res., 29 (1971) 673.PubMedGoogle Scholar
  18. 18.
    Brady, L. and Dodson, G., Nature, 368 (1994) 692.PubMedGoogle Scholar
  19. 19.
    Regoli, D. and Barabe, J., Pharmacol. Rev., 32 (1980) 1.PubMedGoogle Scholar
  20. 20.
    Hunyadi, L., Balla, T. and Catt, K.J., Trends Pharmacol. Sci., 17 (1996) 135.PubMedGoogle Scholar
  21. 21.
    Otter, A., Bigler, P., Stewart, J.M. and Kotovych, G., Biopolymers, 33 (1993) 769.PubMedGoogle Scholar
  22. 22.
    Matsoukas, J.M., Agelis, G., Wahhab, A., Hondrelis, J., Panaiotopoulos, D., Yamdagni, R., Wu, Q., Mavromoustakos, T., Maia, H.L.S., Ganter, R. and Moore, G.J., J. Med. Chem., 38 (1995) 4660.PubMedGoogle Scholar
  23. 23.
    Bünning, P., Holmquist, B. and Riordan, J.F., Biochemistry, 22 (1983) 103.PubMedGoogle Scholar
  24. 24.
    Carmona, A.K. and Juliano, L., Biochem. Pharmacol., 51 (1996) 1051.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • John Howl
  • Mark Wheatley

There are no affiliations available

Personalised recommendations